A placebo-controlled trial to investigate the safety and efficacy of Penicillin G/Hydrocortisone in patients with ALS (PHALS trial)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A placebo-controlled trial to investigate the safety and efficacy of Penicillin G/Hydrocortisone in patients with ALS (PHALS trial)

Published:2020-07-06 Issue:7-8 Volume:21 Page:584-592
ISSN:2167-8421
Container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
language:en
Short-container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Author:

Van Es Michael A.¹,Van Eijk Ruben P.A.¹²,Bunte Tommy M.¹,Van Den Berg Leonard H.¹

Affiliation:

1. Department of Neurology, UMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, the Netherlands

2. Biostatistics & Research Support, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands

Funder

Dutch ALS foundation

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678421.2020.1788093

Reference23 articles.

1. Treatment with penicillin G and hydrocortisone reduces ALS-associated symptoms: a case series of three patients

2. Syphilis may be a confounding factor, not a causative agent, in syphilitic ALS

3. ALSUntangled 46: penicillin G/hydrocortisone

4. Amyotrophic lateral sclerosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Nanoparticle-Based Approach for the Blood–Brain Barrier Passage in a Murine Model of Amyotrophic Lateral Sclerosis;Cells;2022-12-10

2. New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022;Frontiers in Pharmacology;2022-11-28

3. ALSUntangled #65: glucocorticoid corticosteroids;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2022-08-23

4. Clinical studies in amyotrophic lateral sclerosis;Current Opinion in Neurology;2022-08-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3